Unable to stop the new Medicaid average manufacturer’s price-based payment stampede unleashed last month by the Centers for Medicare & Medicaid Services, the retail pharmacy industry has turned for relief to Congress and the states.
America’s favorite bedtime snack lost its patent in April of this year, spawning an immediate rash of 13 approvals of its generic equivalent within two days.The expiration of the patent for Sanofi-Aventis’ $2.2 billion sleep medication, Ambien, on April 21 was nothing to snooze over.
Since sweeping back into power with control of both houses of Congress in January, the Democratic Party has learned anew a bitter lesson in politics: Being the majority party doesn’t necessarily translate into legislative success.
In an apparent effort to keep cough and cold medications like those containing dextromethorphan accessible in OTC aisles, the National Association of Chain Drug Stores NACDS Foundation last month joined such organizations as the Consumer Healthcare Products Association in educating the public on th
Diabetes, a disease with no cure, now is affecting 7 percent of the U.S. population, or 20.8 million adults and children.The disease impacts the body’s ability to produce insulin, resulting in high glucose or blood sugar levels.